More and more individuals use – be it on purpose or unknowingly – devices that track medical and behavioural data, and the cost of such devices is steadily falling, contributing further to their integration into daily
SCOR announces the publication of its interim financial report for the six months ended 30 June 2015
Over 35 million people in the world are HIVpositive. Again, as long as treatment and regular medical follow-up show an absence of immunosuppression, some of these people can be offered life cover.
In the run up to the Climate conference due to be held in Paris in 2015 (COP 21), the Toulouse School of Economics, the Geneva Association and the SCOR Corporate Foundation for Science will be holding an international
SCOR delivers high quality net income of EUR 175 million and annualized ROE of 12.1%
SCOR delivers high quality net income of EUR 175 million and annualized ROE of 12.1%.
SCOR delivers high quality net income of EUR 175 million and annualized ROE of 12.1%
SCOR Global Life Embedded Value increases 6.2% to EUR 4.7 billion in 2014 (EUR 25.5 per share), continuing to provide the Group with significant earnings and strong capital repatriation
SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders’ equity, and proposes a dividend of EUR 1.40, up 8%
SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders’ equity, and proposes a dividend of EUR 1.40, up 8%
SCOR Global Life has entered into a longevity insurance transaction with Sun Life Assurance Company of Canada (Sun Life).
